Mutations co‐occurring in TP53 and ATRX were associated with improved survival compared with either mutation alone (Kaplan–Meier, log‐rank p < .05), indicating a co‐mutation pattern facilitates tumour cell survival. The gene discussed is TP53; the disease is neoplasm.